genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Grant for Genome Engineer Innovation Offered by Synthego
News
Potential Leukemia Drug Target Found in Epigenetic Protein
News
Israel’s Sheba Medical Center to Manufacture Cell Therapies Using Lonza’s Cocoon…
News
Plant Cellulose May Provide Novel Bone Implant Material
Neuroscience
Alcohol Dependency Curbed by Reversibly Inhibiting Specific Neurons
Insights
Commentary
Limitations in Single-Cell Analysis Must Be Addressed with Innovation
Cannabinoids
Liquid Gold: Engineers Strike Oil Making Customized Extractors for Cannabis
Bioprocessing
Addressing Challenges Posed by the Adoption of Single-Use Systems
Insights
Top 15 Best-Selling Drugs of 2018
Insights
Phage Therapy: Turning the Tables on Bacteria
A-Lists
Insights
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
March 2019 Vol. 39 No. 3
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Insights
Top 10 Global Biopharma IPOs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Potential Leukemia Drug Target Found in Epigenetic Protein
News
Israel’s Sheba Medical Center to Manufacture Cell Therapies Using Lonza’s Cocoon…
News
Plant Cellulose May Provide Novel Bone Implant Material
Neuroscience
Alcohol Dependency Curbed by Reversibly Inhibiting Specific Neurons
Magazine
All
Supplement
Insights
Phage Therapy: Turning the Tables on Bacteria
March 2019 Vol. 39 No. 3
Keeping Up with Bioprocess Changes
March 2019 Vol. 39 No. 3
Circulating Tumor Cells and the Liquid Biopsy
Insights
Novel Oncology Drug Discovery Strategies
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
Multiplexed Target Enrichment and High-Resolution NGS Analysis of On- and…
Webinars
Fibro-Inflammatory Disease Sees Relief in IL-11 mAb Development
eBooks
End Uncertainty: Break Through the Roadblocks to Monoclonal Antibody (mAb) Characterization
GENcast
GENcast: Explore, Learn, and Collaborate on Cell & Gene Therapy Manufacturing…
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Companies
GlaxoSmithKline
GlaxoSmithKline
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
GlaxoSmithKline
GSK to Co-Develop Merck KGaA’s Cancer Immunotherapy Candidate M7824 in $4.2B Alliance
GlaxoSmithKline
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
GlaxoSmithKline
GSK to Acquire PARP Inhibitor Developer Tesaro for $5.1B
GlaxoSmithKline
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
GlaxoSmithKline
GSK Sells Psoriasis/Dermatitis Candidate Tapinarof to Dermavant
GlaxoSmithKline
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
GlaxoSmithKline
GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
GlaxoSmithKline
From J.P. Morgan: More Capital Will Boost Biopharma M&A in 2018
GlaxoSmithKline
GSK, Plasticell Partner to Produce Hematopoietic Cells from iPSCs
GlaxoSmithKline
Citing Patient Deaths, FDA Panel Faults Safety Data for J&J Arthritis...
GlaxoSmithKline
GSK Launches Up-to-$43M AI-Focused Collaboration with Exscientia
GlaxoSmithKline
Epizyme Receives $10M Milestone Payment from GSK
GlaxoSmithKline
OncoMed Reviews Portfolio after Tarextumab, Brontictuzumab Setbacks
GlaxoSmithKline
Regeneron, GSK, UK Biobank Launch Gene-Sequencing Collaboration
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-265x198.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")
